Synta Pharmaceuticals Corp. (NASDAQ:SNTA) announced financial results for the recently concluded 3Q2015. As per the reports, the biggest highlight was its announcement to fire almost 60% of its full-time employees due to revenue pressure. Insights of The Matter Going forward, not more than 33 full-time employees will work for Synta Pharmaceuticals. As a result of […]
Chen Schor
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) CEO Steps Down After Less Than A Year, Leaving A Biotech On The Mend
Anne Whitaker is stepped down as CEO of Synta Pharmaceuticals Corp. (NASDAQ:SNTA) just nine months after she got the position. Whitaker left the company in a state of disarray as the company tries to cut down its operations to limit losses. The former CEO joined Synta less than a year ago after leaving Sanofi SA […]
